Autopsy report · NCT04397172
Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19
Cause of deathStaffing, sites or logistics
“Number of Covid-19 cases who need intensive care have greatly reduced, it is very difficult to find eligible patients for the study”
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 3 years 8 months before it stopped.
- 48 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Sponsor type
- University, hospital or other
- Conditions
- COVID; Corona Virus Infection; Sars-CoV2
- Interventions
- Study Arm
- Participants
- 48
- Sites
- 1
- Countries
- Switzerland
Trials that died the same way
- Ivermectin in Adults With Severe COVID-19.
“Lack of severe COVID-19 cases in the place of study” - Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection
“lack of Covid-19 patients” - Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms
“A total of 21 patients were enrolled in the study resulting in 97 total collected specimen time points. Patient recruitment was halted due to greatly decreased numbers of patient hospitalizations for Covid-19.” - Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients
“Difficult patient recruitment due to COVID-19 epidemic” - Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19
“Due to lower COVID-19 cases and therefore difficulties with the recruitment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.